Search trials – HealthDB

Активни: Recruiting ×

Намерени 4,436 изпитвания Стр. 76 от 222

Recruiting

Using Exercise to Enhance Fear Extinction Learning

PTSD Exercise Intensity Fear Extinction Fear Conditioning

The goal of the current project is to establish the efficacy and mechanisms of exercise-enhanced fear extinction retrieval and generalization in posttraumatic stress disorder (PTSD). Exposure therapy is the gold standard treatment for PTSD, yet is only associated with remission rates of \~55% and in clear need of improvement. Exposure therapy is hypothesized to work through mechanisms of fear extinction learning, and as such, laboratory-based fear extinction paradigms are widely used as models of exposure therapy. Recent data demonstrates that moderate-intensity aerobic exercise, delivered specifically during or after fear extinction learning, can boost the consolidation of fear extinction learning. Consistent with emerging models of exercise's pro-extinction effect, our pilot data among women with PTSD found that moderate intensity aerobic exercise delivered after fear extinction learning leads to a reduction in subsequent fear responding 24hrs later, an effect that was mediated by exercise-induced increases in peripheral brain derived neurotrophic factor (BDNF). Our pilot data using multivariate pattern analyses (MVPA) also identified divided neurocircuitry organization of fear vs safety memories, and that this divided neural organization was altered in PTSD. Building on our pilot data, the current project would 1) compare the impact of different intensities of exercise delivered following fear extinction learning on multimodal measures of fear extinction retrieval and generalization, 2) identify the impact of exercise on MVPA representations of fear vs safety memories, and 3) demonstrate that spontaneous reactivations of extinction encodings in the acute consolidation window operate as candidate mechanisms by which exercise enhances extinction retrieval and generalization. Using a 3-day fear conditioning, fear extinction, and fear extinction retrieval and recognition task during functional magnetic resonance imaging (fMRI), 200 adults with PTSD would be randomly assigned to either resting control or 30min of either light, moderate, or high intensity exercise. Testing dose-response relationships between exercise intensity and fear extinction will inform translation of this research to clinical settings. A one week-follow-up extinction retrieval test would investigate the impact of exercise on longer-term retention. This project would provide a critical evaluation of the impact of aerobic exercise on consolidation and recall of extinction learning in PTSD samples, thereby providing a strong foundation to translate this research to clinical care and enhance clinical outcomes for PTSD. The project would also provide general knowledge regarding dose-response relationships and neural mechanisms that support enhanced extinction, thereby informing development of additional novel treatments.

Начало: 02.09.2025 Край: 01.05.2030 Възраст: 18–55 г.

United States Josh Cisler NCT07548125

Recruiting Phase 3

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Neoplasms

The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in combination with best supportive care (BSC) as compared to placebo with BSC in participants with metastatic castration-resistant prostate cancer (mCRPC; a stage of cancer that has spread beyond the prostate gland and is no longer responding to hormone therapies).

Начало: 02.09.2025 Край: 30.05.2028 Възраст: от 18 г. Treatment

Australia, Belgium, Brazil +14 Janssen Research & Development, LLC NCT07164443

Recruiting Phase 1/2

Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve

Diminished Ovarian Reserve

The purpose of this clinical trial is to evaluate the efficacy and safety of Bushen Yiqi formula combined with dehydroepiandrosterone (DHEA) in the treatment of women with diminished ovarian reserve (DOR). The study also aims to assess the safety profile of this combined therapy. The main questions this study aims to answer include: 1. Can the Bushen Yiqi formula combined with DHEA improve ovarian reserve in women with DOR? 2. Does the combined treatment improve hormone levels, ovarian follicle parameters, and clinical symptoms? 3. What safety issues may occur during treatment with the Bushen Yiqi formula combined with DHEA? Researchers will compare the Bushen Yiqi formula combined with DHEA to DHEA plus placebo to determine whether the combined therapy is more effective in treating diminished ovarian reserve. Participants will: 1. Be randomly assigned to either the treatment group or the control group 2. Receive DHEA combined with the Bushen Yiqi formula or DHEA combined with placebo for 12 weeks 3. Undergo regular clinical assessments during the study period 4. Have ovarian reserve markers (including AMH and antral follicle count), sex hormone levels (FSH, LH, E2, and testosterone), traditional Chinese medicine symptom scores, Kupperman menopausal index scores, inflammatory markers (CRP and IL-6), and safety indicators evaluated before and after treatment

Начало: 01.09.2025 Край: 01.12.2027 Възраст: 20–40 г.

China Jiangxi University of Traditional Chinese Medicine NCT07535983

Recruiting

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

Asthma COPD

The goal of this observational study is to determine the prevalence of asthma and chronic obstructive pulmonary disease (COPD) among workers in an industrial zone in Thailand. The main question the study aims to answer is: What is the prevalence of asthma and COPD among workers in Thailand? Participants will complete a questionnaire on respiratory symptoms and undergo pulmonary function testing.

Начало: 01.09.2025 Край: 31.05.2026 Възраст: от 18 г.

Thailand Thammasat University NCT07383896

Recruiting

Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

Advanced Hepatocellular Carcinoma (HCC)

To evaluate the efficacy and immune microenvironment changes in advanced hepatocellular carcinoma (HCC) patients receiving different first-line immunotherapy.

Начало: 01.09.2025 Край: 01.09.2028 Възраст: от 18 г.

China Fudan University NCT07147101

Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis Severe Asthma ABPA

An open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis

Начало: 01.09.2025 Край: 01.12.2026 Възраст: 18–75 г.

China Qianfoshan Hospital NCT07530770

Recruiting

Gummy Smile and Altered Passive Eruption Prevalence

Altered Passive Eruption of Teeth

This observational epidemiological study aims to assess the prevalence of gummy smile and altered passive eruption in a young adult population, with a focus on the second sextant. Periodontal and aesthetic parameters, along with patient-reported discomfort, will be analyzed to identify potential correlations and underlying anatomical factors.

Начало: 01.09.2025 Край: 01.12.2026 Възраст: 18–50 г.

Italy University of Roma La Sapienza NCT07548398

Recruiting

Mechanical Bowel Preparation in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis

Colon Cancer

This study is a randomized controlled trial conducted at University Medical Center Ho Chi Minh City to evaluate the role of mechanical bowel preparation (MBP) in patients undergoing laparoscopic right hemicolectomy with totally intracorporeal anastomosis for colon cancer. Mechanical bowel preparation is commonly used before colorectal surgery to reduce bowel contents and potentially decrease the risk of postoperative infections. However, its benefit remains controversial, particularly in intracorporeal anastomosis, where intra-abdominal contamination may influence surgical outcomes. In this study, eligible patients will be randomly assigned to one of two groups: with or without mechanical bowel preparation before surgery. The study aims to compare intraoperative events, postoperative complications, and recovery outcomes between the two groups. The primary outcome is the rate of surgical site infection (SSI) within 30 days after surgery. Secondary outcomes include intraoperative fecal contamination, anastomotic leakage, postoperative ileus, operative time, and recovery parameters such as time to first bowel movement and length of hospital stay. The findings of this study are expected to clarify the role of mechanical bowel preparation in reducing postoperative infections and improving surgical outcomes in patients undergoing laparoscopic right hemicolectomy.

Начало: 01.09.2025 Край: 31.10.2027 Възраст: от 18 г.

Vietnam University Medical Center Ho Chi Minh City (UMC) NCT07546565

Recruiting

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Arthritis, Rheumatoid

This open label clinical trial aims to assess the safety of abdominal vagus nerve stimulation (aVNS) for moderate to severe, adult-onset rheumatoid arthritis (RA) that has not responded to medication. The aVNS is an active medical device placed into the body to allow electrical stimulation of the abdominal vagus nerve. Participants will undergo stimulation treatment with the aVNS device from two to 24 weeks after the device is implanted by keyhole surgery. Safety, device performance and potential benefits will be assessed. Participants will be monitored for specific events for 5 years post surgery.

Начало: 01.09.2025 Край: 01.12.2031 Възраст: 18–75 г. Device feasibility

Australia The Bionics Institute of Australia NCT07017686

Recruiting

Neural Mechanisms of Interpersonal Expectations on Negative Affect

Negative Affectivity Non-invasive Brain Stimulation Placebo Effect Expectations

The goal of this clinical trial is to learn whether non-invasive brain stimulation, called transcranial temporal interference stimulation (tTIS), can reduce negative affect, and how expectations shaped by care providers influence these effects. The main questions this study aims to answer are: (1)Does active tTIS reduce negative affect more effectively than sham (inactive) tTIS? (2)Do positive treatment expectations enhance the effects compared to negative expectations? Participants will: (1) Receive either active or sham tTIS. (2) Be provided with positive or negative messaging regarding treatment effectiveness. (3) Interact with care providers and complete assessments measuring negative affect and physiological responses.

Начало: 01.09.2025 Край: 03.03.2028 Възраст: 18–55 г.

United States Trustees of Dartmouth College NCT06980090

Recruiting

Early Partial Weight-bearing May Improve Functional Recovery Without Increasing Complications Despite This Potential, Limited Randomized Studies Have Evaluated Early Weight-bearing After Pelvic Fixation Surgeries

Pelvic Fractures Weight Bearing

The goal of this randomized clinical trial is to compare between the effect of immediate weight bearing (WB) versus delayed weight bearing in improving function, pain, gait, quality of reduction radiologically, muscle strength, and quality of life outcomes in individuals who underwent specific pelvic fixation surgeries.

Начало: 31.08.2025 Край: 01.06.2026 Възраст: 18–55 г.

Egypt Assiut University NCT07538726

Recruiting Phase 2

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

Retinitis Pigmentosa

The goal of the study is to investigate the safety, tolerability and efficacy of up to 3 doses of KIO-301 administered by intravitreal (IVT) injection bilaterally every 6 weeks in patients with late-stage retinitis pigmentosa (RP). Late-stage RP patients will include those patients with No Light Perception (NLP), or Low Vision (LV).

Начало: 29.08.2025 Край: 01.08.2027 Възраст: от 18 г. Treatment

Australia Kiora Pharmaceuticals, Inc. NCT06628947

Recruiting Phase 2/3

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors

There is limited evidence regarding the benefit of adding somatostatin analogs to molecular targeted agents for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) with poor prognostic factors. This trial is conducted to evaluate sirolimus for injection (albumin bound) combined with octreotide long-acting injection in patients with unresectable or recurrent GEP-NETs.

Начало: 29.08.2025 Край: 29.08.2028 Възраст: от 18 г.

China CSPC ZhongQi Pharmaceutical Technology Co., Ltd. NCT07165886

Recruiting Phase 1

A Study of LY4064912 in Healthy Participants and With Overweight or Obesity

Overweight or Obesity Healthy

The purpose of this study is to evaluate how well LY4064912 is tolerated and what side effects may occur in healthy participants and participants with overweight and obesity - global. The study drug will be administered either subcutaneously (SC) (under the skin) or infusion intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

Начало: 28.08.2025 Край: 01.11.2026 Възраст: 18–65 г.

Singapore, United States Eli Lilly and Company NCT07152002

Recruiting

Prospective Pathology Foundation Models

Pancancer

Histopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations. This underscores the critical need to develop deep learning-based pathology foundation models integrating prospective imaging and clinical data. Such models would enhance diagnostic accuracy and efficiency, enabling tumor grading, histo-molecular classification, and intelligent chemotherapy guidance - ultimately optimizing clinical workflows. However, a critical gap remains: the absence of prospectively validated, pan-disease pathology foundation models. Developing clinically validated models is therefore imperative.

Начало: 28.08.2025 Край: 01.08.2028 Възраст: 18–75 г.

China Nanfang Hospital, Southern Medical University NCT07157618

Recruiting Phase 2

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

IgAN C3G Complement-mediated Kidney Disease IgA Nephropathy (IgAN) +1

This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated kidney diseases.

Начало: 28.08.2025 Край: 01.06.2029 Възраст: от 18 г. Treatment

Australia, Hong Kong, South Korea +3 ADARx Pharmaceuticals, Inc. NCT06989359

Recruiting

Cold Water and Decision-Making

Behavior Stress Quality of Life Psychological Wellbeing

The behavioral within-subject cross-over design study "CoVa" aims to investigate the effect of a short-term full-body cold-water immersion vs. warm-water immersion control on value-based choice, psychological well-being, and peripheral physiology.

Начало: 28.08.2025 Край: 31.12.2026 Възраст: 18–40 г.

Germany German Institute of Human Nutrition NCT06908447

Recruiting Phase 1/2

A Study of LM-350 in Subjects With Advanced Solid Tumours

Malignant Tumors

For Phase I Dose Escalation Stage, to assess the safety and tolerability of LM-350 in patients with advanced solid tumors,determine the maximum tolerated dose (MTD) or optimal biological dose (OBD), and explore the relationship between the biomarkers and the anti-tumor activity of LM-350. For Phase II Dose Expansion Stage, to assess the preliminary anti-tumor activity of LM-350 in patients with advanced solid tumors.

Начало: 28.08.2025 Край: 30.06.2030 Възраст: от 18 г. Treatment

Australia, China LaNova Medicines Limited NCT07112222

Recruiting Phase 1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

KCNT1-Related Epilepsy

This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.

Начало: 28.08.2025 Край: 01.03.2026 Възраст: 18–55 г. Treatment

Australia Actio Biosciences, Inc. NCT07156201

Recruiting Phase 3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary Angioedema HAE Hereditary Angioedema - Type 1 Hereditary Angioedema - Type 2

This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.

Начало: 28.08.2025 Край: 31.12.2027 Възраст: от 18 г. Treatment

Argentina, Australia, Austria +16 ADARx Pharmaceuticals, Inc. NCT06960213

1 … 74 75 76 77 78 … 222